Moleculin Biotech (MBRX) has received FDA feedback and guidance on its IND amendment that has allowed a reduction in the size of its Phase 3 ...

Acres Farms, the vertical farming startup headquartered in Hamilton, announced Monday, Feb. 10, capital raises last year ...

Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing tumor-specific immunity against multiple cancer types ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Moleculin Biotech (MBRX) has received first country regulatory approval in Europe to begin recruiting for its Phase 3 pivotal trial protocol ...

Henry Gosebruch, Neumora’s CEO since 2023, will depart. Elsewhere, Biogen dropped two antisense drugs in a pipeline cull and Voyager hit a setback for its ALS gene therapy.

US-based pharmaceutical company Moleculin Biotech has received approval from Ukraine's Ministry of Health to begin enrolment in its Phase III trial of annamycin with cytarabine for treating acute ...

ShreeGanesh Bio Standalone September 2024 Net Sales at Rs 1.98 crore, down 51.82% Y-o-Y Oct 24 2024 11:46 AM ShreeGanesh Bio Standalone June 2024 Net Sales at Rs 3.56 crore, down 56.92% Y-o-Y Aug ...

Genomic Valley Standalone June 2024 Net Sales at Rs 0.16 crore, up 165.24% Y-o-Y Jul 30 2024 02:19 PM Genomic Valley Standalone December 2023 Net Sales at Rs 0.04 crore, down 94.2% Y-o-Y Feb 16 ...

Concord Biotech Limited was originally incorporated as `Servomed Pharmaceuticals Private Limited' at Ahmedabad Gujarat as a Private Limited Company dated November 23 1984 issued by the Registrar of ...